These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19480802)

  • 1. [Acute myocardial infarction and pemetrexed].
    Pío-Asín M; Segrelles-Bellmunt G; Arrondo-Velasco A; Sarobe-Carricas M
    Farm Hosp; 2009; 33(2):114-5. PubMed ID: 19480802
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute renal failure associated with Pemetrexed (Alimta)].
    Porta JM; Vicente de Vera Floristán C; Inglán PB; Jericó JF
    Nefrologia; 2009; 29(6):610-1. PubMed ID: 19936010
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal pemetrexed-induced lung injury in patients with advanced mesothelioma: a report of two cases.
    Nagata K; Kaji R; Tomii K
    J Thorac Oncol; 2010 Oct; 5(10):1714-5. PubMed ID: 20871270
    [No Abstract]   [Full Text] [Related]  

  • 4. Pemetrexed-induced anaphylaxis.
    Shah BK; Hewett Y
    Acta Oncol; 2013 May; 52(4):881. PubMed ID: 23472834
    [No Abstract]   [Full Text] [Related]  

  • 5. Pemetrexed-associated radiation recall dermatitis.
    Khanfir K; Anchisi S
    Acta Oncol; 2008; 47(8):1607-8. PubMed ID: 18607836
    [No Abstract]   [Full Text] [Related]  

  • 6. Pemetrexed-induced skin sclerosis.
    Merklen-Djafri C; Imbert E; Courouge-Dorcier D; Schott R; Méraud JP; Muller C; Tebacher M; Springinsfeld G; Cribier B; Lipsker D
    Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):452-3. PubMed ID: 22397832
    [No Abstract]   [Full Text] [Related]  

  • 7. Image of the month. Rash in a patient treated with pemetrexed for relapsed non-small cell lung cancer.
    Declercq I; Lievens Y; Verbeken E; Vansteenkiste J
    J Thorac Oncol; 2008 Jun; 3(6):662-3. PubMed ID: 18520810
    [No Abstract]   [Full Text] [Related]  

  • 8. Asteatotic eczema ('eczema craquelé') with histopathological interface dermatitis: a new cutaneous reaction following pemetrexed.
    Frouin E; Sebille G; Freudenberger S; Menecier B; Quoix E; Cribier B; Lipsker D
    Br J Dermatol; 2012 Jun; 166(6):1359-60. PubMed ID: 22182200
    [No Abstract]   [Full Text] [Related]  

  • 9. Pemetrexed-induced eyelid edema in lung cancer.
    Martins-Filho PR; Kameo SY; Mascarenhas-Oliveira AC; Vieira NF; Azevedo E
    J Craniofac Surg; 2013 Jul; 24(4):e401-3. PubMed ID: 23851735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemetrexed as a possible cause of severe rhabdomyolysis in the treatment of lung cancer.
    Huang MS; Tsai JR; Shen MC; Chou SH; Yang CJ
    Lung Cancer; 2012 Jun; 76(3):491-2. PubMed ID: 22405568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune hemolytic anemia after treatment with pemetrexed for lung cancer.
    Park GM; Han KS; Chang YH; Kim CH; Lee JC
    J Thorac Oncol; 2008 Feb; 3(2):196-7. PubMed ID: 18303446
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of pemetrexed in the treatment of advanced non-small-cell lung cancer: news from ASCO, 2008].
    de Marinis F; Ricciardi S
    Tumori; 2008; 94(5):suppl 3-13. PubMed ID: 19112963
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of pemetrexed-induced acute lung injury in non-small cell lung cancer.
    Kim HO; Lee SY; Shim JJ; Kang KH; Shin BK
    J Thorac Oncol; 2010 Mar; 5(3):401-2. PubMed ID: 20186027
    [No Abstract]   [Full Text] [Related]  

  • 14. Pemetrexed-induced fluid retention.
    Bastos DA; Calabrich A; Katz A
    J Thorac Oncol; 2010 May; 5(5):752. PubMed ID: 20421771
    [No Abstract]   [Full Text] [Related]  

  • 15. Pemetrexed-induced typhlitis in non-small cell lung cancer.
    Shvartsbeyn M; Edelman MJ
    J Thorac Oncol; 2008 Oct; 3(10):1188-90. PubMed ID: 18827618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis.
    Pujol JL; Paul S; Chouaki N; Peterson P; Moore P; Berry DA; Salzberg M
    J Thorac Oncol; 2007 May; 2(5):397-401. PubMed ID: 17473654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Painful generalized erythematous patches: a severe and unusual cutaneous reaction to pemetrexed.
    Vitiello M; Romanelli P; Kerdel FA
    J Am Acad Dermatol; 2011 Jul; 65(1):243-4. PubMed ID: 21679840
    [No Abstract]   [Full Text] [Related]  

  • 18. The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer.
    Kim YS; Sun JM; Ahn JS; Ahn MJ; Park K
    Lung Cancer; 2013 Aug; 81(2):231-5. PubMed ID: 23683535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed (Alimta) for mesothelioma.
    Med Lett Drugs Ther; 2004 Apr; 46(1180):31-2. PubMed ID: 15079145
    [No Abstract]   [Full Text] [Related]  

  • 20. Skin toxicities compromise prolonged pemetrexed treatment.
    Eguia B; Ruppert AM; Fillon J; Lavolé A; Gounant V; Epaud C; Milleron B; Moguelet P; Wislez M; Frances C; Cadranel J
    J Thorac Oncol; 2011 Dec; 6(12):2083-9. PubMed ID: 21892100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.